Navigation Links
Myriant to Participate in U.S. DOE Biomass 2013 Conference
Date:7/29/2013

Quincy, MA (PRWEB) July 29, 2013

Myriant Corporation today announced that Sue Hager, Myriant’s Senior Vice President of Corporate Communications and Government Affairs, will participate in the U.S. Department of Energy (DOE) Event, Biomass 2013: How the Advanced Bioindustry is Reshaping American Energy. Ms. Hager will present as part of the Conference’s opening plenary session titled “Celebrating Successes ? The Foundation of an Advanced Bioindustry,” on Wednesday, July 31st, 2013, from 10:10 a.m. ? 11:30 p.m. EST. The Biomass 2013 Conference will take place at the Washington, D.C. Convention Center.

About Myriant Corporation
Myriant is a global leader innovating and commercializing bio-based chemical intermediates. Myriant enables its customers to achieve their sustainability initiatives by utilizing renewable feedstocks to produce high-value, cost-advantaged chemicals, including bio-succinic acid and its derivatives. Myriant is currently commercializing its bio-succinic acid platform from two operating chemical plants: The first is Myriant's flagship plant in Lake Providence, LA; the other, a commercial validation facility located in Leuna, Germany, which is operated by Myriant's global partner, ThyssenKrupp Uhde. Myriant, together with Johnson Matthey - Davy Technologies (JM Davy), combined the efficiencies of their respective chemical processes for the production of cost-competitive bio-BDO and bio-THF made from Myriant's bio-succinic acid, yielding overall carbon efficiency of 87%. Myriant is also advancing its proprietary, low-cost, high-purity process for bio-acrylic acid. Myriant is a 2013 Red Herring Top 100 Company in North America. More information about Myriant's pipeline of renewable chemicals can be found at http://www.myriant.com.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10956087.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Piedmont Chemical Launches 100 Percent Renewable Polyester Polyols Leveraging Renewable Chemicals from DuPont Tate & Lyle Bio Products and Myriant Corporation
2. ViroPharma to Participate in Two December Healthcare Investor Conferences
3. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
4. Medical Experts Who Participated in CSL Behrings Key Issues Dialogue Prefer Albumin for Fluid Management
5. Genomind to Participate in National Alliance on Mental Illness (NAMI) 2012 National Convention
6. Elsevier to Participate in SCOAP3 With the Journals Physics Letters B and Nuclear Physics B
7. Biosim Pharmaceuticals, Manufacturers of Generic ACTHAR, to Participate at Biotech Showcase 2013
8. Vermillion to Participate in Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference on February 27, 2013
9. AVANIR Pharmaceuticals To participate in two conferences in March
10. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
11. ViroPharma To Participate In Two May Healthcare Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
Breaking Biology Technology:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
Breaking Biology News(10 mins):